COBENFY 100 MG-20 MG CAPSULE

xanomeline and trospium chloride
$30.3016per EA

Strength

20; 100 mg/1; mg/1

NDC

00003110060

Classification

Brand

Dosage Form

CAPSULE, COATED PELLETS

Route

ORAL

Last Updated

1/1/2026

Approval Type

New Drug (NDA)

FDA Application

NDA216158

On Market Since

9/27/2024

Pharmacological Classes

Cholinergic Muscarinic Agonist
Cholinergic Muscarinic Agonists
Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.2%

1Y

+2.0%

3Y

N/A

5Y

N/A

All

+1.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.